Диссертация (1090334), страница 19
Текст из файла (страница 19)
– 396 p.71. Antibacterial ciprofloxacin hydrochloride incorporated PVA/regenerated silkfibroin nanofibers composite for wound dressing applications [Text] / A. A. El-Shanshory,W. Chen, H. A. El-Hamshary [et al.] // J. Control. Release. – 2015. – Vol. 213.
– P. e8-e9.72. Berkner, S. Biodegradability and transformation of human pharmaceuticalactive ingredients in environmentally relevant test systems [Text] / S. Berkner,C. Thierbach // Environ. Sci. Pollut. Res. Int. – 2014. – Vol. 21, № 16. – P. 9461-9467.73. Bikiaris, D. N. Solid dispersions, part I: recent evolutions and futureopportunities in manufacturing methods for dissolution rate enhancement of poorlywater-soluble drugs [Text] / D.
N. Bikiaris // Expert Opin. Drug Deliv. – 2011. – Vol. 8,№ 11. – P. 1501-1519.74. Biodegradable nanofibrous drug delivery systems: Effects of metronidazoleand ciprofloxacin on periodontopathogens and commensal oral bacteria [Text] /M. C. Bottino, R. A. Arthur, R. A. Waeiss [et al.] // Clin. Oral Invest. – 2014. – Vol.
18,№ 9. – P. 2151-2158.75. CH Topic Q 2 (R1) Validation of Analytical Procedures [Electronic resource] :Text and Methodology : June 1995, CPMP/ICH/381/95 / European Medicines Agency. –London, 2006. – 15 p. – Mode of access: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002662.pdf.76. Chen, H.-M.
An elevated temperature electrospinning process for preparingacyclovir-loaded PAN ultrafine fibers [Text] / H.-M. Chen, D.-G. Yu // J. Mater.Process. Technol. – 2010. – Vol. 210, № 12. – P. 1551-1555.77. Determination of mechanical properties of carbon nanotubes and verticallyaligned carbon nanotube forests using nanoindentation [Text] / H. J.
Qi, K. B. K. Teo,K. K. S. Lau [et al.] // J. Mech. Phys. Solids. – 2003. – Vol. 51, № 11-12. – P. 22132237.11978. Doan, T. A woman with bilateral maculopathy and acquired vitamin B12deficiency [Text] / T. Doan, J. R. Chao // Eye (Lond). – 2014. – Vol. 28, № 7. – P. 905906.79. Electrohydrodynamics: a facile technique to fabricate drug delivery systems[Text] / S. Chakraborty, I. C.
Liao, A. Adler [et al.] // Adv. Drug Del. Rev. – 2009. –Vol. 61, № 12. – P. 1043-1054.80. Electrosprayed core-shell solid dispersions of acyclovir fabricated using anepoxy-coated concentric spray head [Text] / Z.-P. Liu, L. Cui, D.-G. Yu [et al.] // Int.J. Nanomedicine. – 2014. – Vol. 9. – P. 1967-1977.81. Electrospunnanofibersin drug delivery: recent developmentsandperspectives [Text] / G. R. Williams, N. P. Chatterton, T. Nazir [et al.] // Ther. Deliv.
–2012. – Vol. 3, № 4. – P. 515-533.82. Electrospun/electrosprayed polyurethane biomembranes with ciprofloxacinand clove oil extract for urinary devices [Electronic resource] / D. Macocinschi,D. Filip, S. Vlad [et al.] // J. Bioact. Compat. Polym. – 2015. – Vol. 30, № 5. – P. 509523.Modeofaccess:http://jbc.sagepub.com/content/early/2015/04/10/0883911515581508.full.pdf+html.83. Enhancement of solubility of acyclovir by solid dispersion and inclusioncomplexation methods [Text] / N.
K. Sachan, S. S. Solanki, P. Kannojia [et al.] // WorldAppl. Sci. J. – 2010. – Vol. 11, № 7. – P. 857-864.84. Guidelines for ATC classification and DDD assignment [Text] / NorwegianInstitute of Public Health, WHO Collaborating Centre for Drug Statistics Methodology. – 6ed. – Oslo : WHO Collaborating Centre for Drug Statistics Methodology, 2004. – 261 p.85.
Haghjou, N. Retina-choroid-sclera permeability for ophthalmic drugs in thevitreous to blood direction: quantitative assessment [Text] / N. Haghjou, M. J.Abdekhodaie, Y.-L. Cheng // Pharm. Res. – 2013. – Vol. 30, № 1. – P. 41-59.86. Harvey, R. P. Microbiology [Text] / R. P. Harvey, P.
C. Champe, B. Fisher. –2nd ed. – Philadelphia : Lippincott Williams & Wilkins, 2007. – 438 p. – (Lippincott’sIllustrated Reviews).12087. Inorganic nanowires [Text] / C. N. R Rao, F. L Deepak, G. Gundiah [et al.] //Progress in Solid State Chemistry. – 2003. – Vol. 31, № 1. – P. 5-147.88. John, B. Intravitreal injection [Text] / B.
John // Kerala Journal ofOphthalmology. – 2007. – Vol. 19, № 1. – P. 46-57.89. Jouan, M. Management of CMV retinitis in the era of highly activeantiretroviral therapy [Text] / M. Jouan, C. Katlama // Int. J. Antimicrob. Agents. –1999. – Vol. 13, № 1. – P. 1-7.90. Koevary, S.
B. Pharmacokinetics of topical ocular drug delivery: potentialuses for the treatment of the posterior segment and beyond [Text] / S. B. Koevary //Curr. Drug Metab. – 2003. – Vol. 4, № 3. – P. 213-222.91. Kuno, N. Recent advances in ocular drug delivery systems [Text] / N. Kuno,S. Fujii // Polymers. – 2011. – Vol. 3, № 1.
– P. 193-221.92. Leach, A. R. An Introduction to chemoinformatics [Text] / A. R. Leach, V. J.Gillet. – Dordrecht [u. a.] ; Kluwer Academic Publ., 2003. – 259 p.93. Management of ocular neuropathic pain with vitamin b12 supplements: a casereport [Text] / R.
Shetty, K. Deshpande, A. Ghosh [et al.] // Cornea. – 2015. – Vol. 34,№ 10. – P. 1324-1325.94. McDonald, M. B. New antibiotic option for the treatment of blepharitis[Electronic resource] / M. B. McDonald // EyeWorld / American Society of CataractandRefractiveSurgery.–2009.–August.–Modeofaccess:http://eyeworld.org/article.php?sid=5064.95. Mechanical properties of a single electrospun fiber and its structures [Text] /S. Y. Gu, Q. L.
Wu, J. Ren [et al.] // Macromol. Rapid. Commun. – 2005. – Vol. 26, №9. – P. 716-720.96. Patel,D.Oral bioavailabilityenhancementofacyclovirbyself-microemulsifying drug delivery systems (SMEDDS) [Text] / D. Patel, K. K. Sawant //Drug Dev. Ind. Pharm. – 2007. – Vol. 33, № 12. – P. 1318-1326.97.
Patel, R. P. Physicochemical characterization and dissolution study of soliddispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30121[Text] / R. P. Patel, M. M. Patel // Pharm. Dev. Technol. – 2007. – Vol. 12, № 1. –P. 21-33.98. Pearson, P. A. Clearance and distribution of ciprofloxacin after intravitrealinjection [Text] / P. A. Pearson, D. P. Hainsworth, P.
Ashton // Retina. – 1993. – Vol.13, № 4. – P. 326-330.99. Peyman, G. A. Intravitreal injection of therapeutic agents[Text] /G. A. Peyman, E. M. Lad, D. M. Moshfeghi // Retina. – 2009. – Vol. 29, № 7. –P. 875-912.100. Pharmacokinetics of sparfloxacin in the serum and vitreous humor ofrabbits:physicochemicalpropertiesthatregulatepenetrationofquinoloneantimicrobials [Text] / W. Liu, Q. F. Liu, R. Perkins [et al.] // Antimicrob. AgentsChemother. – 1998. – Vol.
42, № 6. – P. 1417-1423.101. Physicochemical characterization and in vitro dissolution studies of soliddispersions of ketoprofen with PVP K30 and d-mannitol [Text] / P. S. Yadav, VikasKumar, Udaya Pratap Singh [et al.] // Saudi Pharm. J.
– 2013. – Vol. 21, № 1. – P. 77-84.102. Pollard, R. B. CMV retinitis: ganciclovir/monoclonal antibody [Text] /R. B. Pollard // Antiviral. Res. – 1996. – Vol. 29, № 1. – P. 73-75.103. Polymorphs and hydrates of acyclovir [Text] / K. M. Lutker, R. Quiñones,J. Xu [et al.] // J. Pharm. Sci. – 2011. – Vol. 100, № 3. – P. 949-963.104.
Preparation, Characterization and Stability Studies of Glassy SolidDispersions of Indomethacin using PVP and Isomalt as carriers [Text] / E. Khodaverdi,N. Khalili, F. Zangiabadi [et al.] // Iran. J. Basic Med. Sci. – 2012. – Vol. 15, № 3. –P. 820-832.105. Rubenstein, J. B. Conjunctivitis: infectious and noninfectious [Text] /J. B. Rubenstein, A. Tannan // Ophthalmology / eds.: M. Yanoff, J. S.
Duker. – 4th ed. –London, 2013. – Chapt. 4.6. – P. 183-191.106. Santen to launch on May 13 of Sante Beautéye, a new OTC eye drop[Electronic resource] : News Release / Santen Pharmaceutical Co., Ltd. – Osaka ; SanteBeautéye, 2013. – Mode of access: http://www.santen.com/en/news/20130509.pdf.122107. Sareen, S. Improvement in solubility of poor water-soluble drugs by soliddispersion [Text] / S. Sareen, G. Mathew, L. Joseph // Int.
J. Pharm. Investig. – 2012. –Vol. 2, № 1. – P. 12-17.108. Savjani, K. T. Drug solubility: importance and enhancement techniques[Text] / K. T. Savjani, A. K. Gajjar, J. K. Savjani // ISRN Pharm. – 2012. – Vol. 2012. –Art. 195727.109. Sharma, A. Preparation and characterization of solid dispersions ofcarvedilol with PVP K30 [Text] / A. Sharma, C.
P. Jain // Res. Pharm. Sci. – 2010. –Vol. 5, № 1. – P. 49-56.110. Short, B. G. Safety evaluation of ocular drug delivery formulations:techniques and practical considerations [Text] / B. G. Short // Toxicol. Pathol. – 2008. –Vol. 36, № 1. – P. 49-62.111. Simultaneously enhancing the solubility and permeability of acyclovir bycrystal engineering approach [Text] / Y. Yan, J.-M. Chen, T.-B. Lu // CrystEngComm. –2013. – Vol. 15, № 33.
– P. 6457-6460.112. Solid dispersions in the form of electrospun core-sheath nanofibers [Text] /D.-G. Yu, L.-M. Zhu, C. J. Branford-White [et al.] // Int. J. Nanomedicine. – 2011. –Vol. 6. – P. 3271-3280.113. Solubility of antibiotics in different solvents. Part II. Non-hydrochlorideforms of tetracycline and ciprofloxacin [Text] / A. I.